Recombinant LASV GP1 Protein [His] (VAng-Wyb3672)
Lassa virus (strain Mouse/Sierra Leone/Josiah/1976) GP1, recombinant protein.
Applications
Used for immunoassay.
Formulation
Phosphate buffered saline and 100 mM arginine and 3M urea.
Purity
> 90% pure by SDS-PAGE.
Storage
Store at 4°C short term, -20°C long term.
Introduction
Lassa virus (LASV) is the causative agent of viral hemorrhagic fever-Lassa hemorrhagic fever, belonging to Arenaviridae. The hosts of the virus are human and other primates, and the viruses are mainly prevalent in West African countries. The symptoms of LASV fever are similar to flu, including fever, sore throat, headache, weakness, cough, and gastrointestinal reactions. Effects on bleeding are changes in vascular permeability. The target cells infected with the virus are dendritic cells and epithelial cells, all of which belong to antigen presenting cells. LASV is a single-strand, double-segment RNA virus containing an envelope. The viral genome encodes four viral proteins, including zinc-binding proteins, RNA polymerases, nuclear proteins, and viral glycoproteins. The operation of the virus requires Biosafety Level 4-equivalent containment. LASV is a single-strand, double-segment RNA virus containing an envelope.
Alternative Names
Lassa virus; LASV; Arenaviridae; Arenavirus
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.